| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.007 |